Related Experiment Video
Updated: Dec 3, 2025
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Pathophysiological significance of N-myc downstream-regulated gene 2 in cancer development through protein
Kazuhiro Morishita1, Shingo Nakahata1, Tomonaga Ichikawa1
1Medical Sciences, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Abstract:
N-myc downstream-regulated gene 2 (NDRG2) is a candidate tumor suppressor in various cancers, including adult T-cell leukemia/lymphoma (ATLL). NDRG2, as a stress-responsive protein, is induced by several stress-related signaling pathways and NDRG2 negatively regulates various signal transduction pathways. Although it has not been found to function alone, NDRG2 binds serine/threonine protein phosphatase 2A (PP2A), generating a complex that is involved in the regulation of various target proteins. The main function of NDRG2 is to maintain cell homeostasis by suppressing stress-induced signal transduction; however, in cancer, genomic deletions and/or promoter methylation may inhibit the expression of NDRG2, resulting in enhanced tumor development through overactivated signal transduction pathways. A wide variety of tumors develop in Ndrg2-deficient mice, including T-cell lymphoma, liver, lung and other tumors, the characteristics of which are similar to those in Pten-deficient mice. In particular, PTEN is a target molecule of the NDRG2/PP2A complex, which enhances PTEN phosphatase activity by dephosphorylating residues in the PTEN C-terminal region. In ATLL cells, loss of NDRG2 expression leads to the failed recruitment of PP2A to PTEN, resulting in the inactivation of PTEN phosphatase with phosphorylation, ultimately leading to the activation of PI3K/AKT. Thus, NDRG2, as a PP2A adaptor, regulates the global phosphorylation of important signaling molecules. Moreover, the downregulation of NDRG2 expression by long-term stress-induced methylation is directly correlated with the development of ATLL and other cancers. Thus, NDRG2 might be important for the development of stress-induced leukemia and other cancers and has become an important target for novel molecular therapies.
Insights
N-myc downstream-regulated gene 2 (NDRG2) acts as a tumor suppressor by regulating cell homeostasis. Loss of NDRG2 expression, often due to methylation, promotes cancer development by disrupting signaling pathways like PI3K/AKT.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- N-myc downstream-regulated gene 2 (NDRG2) is a stress-responsive protein implicated as a tumor suppressor in various cancers, including adult T-cell leukemia/lymphoma (ATLL).
- NDRG2 functions by negatively regulating stress-induced signal transduction pathways, maintaining cellular homeostasis.
- Its expression can be inhibited in cancer through genomic alterations or promoter methylation, leading to uncontrolled cell signaling and tumor development.
Purpose of the Study:
- To elucidate the role of NDRG2 in cancer development, particularly in ATLL.
- To investigate the molecular mechanisms by which NDRG2 regulates signaling pathways, focusing on its interaction with protein phosphatase 2A (PP2A) and PTEN.
- To establish NDRG2 as a potential therapeutic target for stress-induced leukemias and other cancers.
Main Methods:
- Analysis of NDRG2 expression in cancer cells and correlation with tumor development.
- Investigating the interaction between NDRG2, PP2A, and PTEN using biochemical assays.
- Studying the impact of NDRG2 loss on PTEN phosphatase activity and downstream signaling pathways like PI3K/AKT in ATLL models.
Main Results:
- NDRG2 binds to PP2A, forming a complex that enhances PTEN phosphatase activity.
- Loss of NDRG2 in ATLL cells prevents PP2A recruitment to PTEN, leading to PTEN inactivation and PI3K/AKT pathway activation.
- NDRG2 deficiency in mice results in various tumors, mirroring characteristics of PTEN-deficient mice, suggesting a critical role in tumor suppression.
Conclusions:
- NDRG2 acts as a crucial tumor suppressor by modulating PTEN activity via the PP2A complex, thereby regulating key signaling pathways.
- Downregulation of NDRG2, particularly through stress-induced methylation, is directly linked to the pathogenesis of ATLL and other cancers.
- NDRG2 represents a promising therapeutic target for novel treatments against stress-induced malignancies.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
The mTOR pathway or the...
02:23Abnormal Proliferation
01:22PI3K/mTOR/AKT Signaling Pathway
01:19Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:07MAPK Signaling Cascades
01:06Induced Pluripotent Stem Cells
Somatic...